Bioasis Technologies

Canada
Port Elgin, Ontario, Canada, V6X 2W8

Company profile

Bioasis Technologies company profile

Bioasis Technologies Inc. is a biopharmaceutical company developing the xB3 ™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need, including brain cancers and neurodegenerative diseases. The delivery of therapeutics across the blood brain barrier represents the final frontier in treating neurological disorders. The in-house development programs at Bioasis are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.

Business identity

Contact email
[email protected]
Phone number
1.203.390.7395
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0+
Founded
2007-01-01, Year

Headquarters

Postal code
V6X 2W8
Country code
CA
Continent
North America

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
3
Total equity funding
$730,000
Last funding
Post IPO Debt / $8.1M / 2021-06-22
Last equity funding
Post IPO Equity / $200,000
Investors
1
Lead investors
1
Founders
1
Articles
19
Exited on
2008-04-03

Founders and investors

Founders

Rob Hutchison

Lead investors

The Lind Partners

Investors

The Lind Partners